In: Nature communications, 2016, vol. 7, p. 13466
Neutralization of the common p40-subunit of IL-12/23 in psoriasis patients has led to a breakthrough in the management of moderate to severe disease. Aside from neutralizing IL-23, which is thought to be responsible for the curative effect, anti-p40 therapy also interferes with IL-12 signalling and type 1 immunity. Here we dissect the individual contribution of these two cytokines to the...
|
In: Pharmaceutical Research, 2008, vol. 25, no. 3, p. 710-710
|
In: Pharmaceutical Research, 2007, vol. 24, no. 10, p. 1927-1935
|
In: Clinical Infectious Diseases, 2013, vol. 56, no. 3, p. 463-464
|